(Q43818660)

English

Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Takuji Okusaka

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Shuichi Okada

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Toshio Nakanishi

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Shigetoshi Fujiyama

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yasuhiko Kubo

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

169-176

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

https://scigraph.springernature.com/pub.10.1023/b:drug.0000011793.72775.d1

0 references

Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE).

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra-arterial infusion chemotherapy of cisplatin (CDDP)-lipiodol suspension using implantable injection port for unresectable liver cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The superselective and the selective one shot methods for treating inoperable cancer of the liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical study on the effect of intra-arterial injection of mitoxantrone-lipiodol emulsion for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arterial chemoembolization with mitomycin C microcapsules followed by transcatheter hepatic artery embolization for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-growing rat hepatic tumor after intra-hepatic arterial administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional intra-arterial infusion of adriamycin in the treatment of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposoluble platinum(II) complexes with antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro release of SM-11355, cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum(II) suspended in lipiodol

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of inoperable hepatocellular carcinoma by intra-arterial Lipiodol and 4?-epidoxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14739665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/B:DRUG.0000011793.72775.D1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43818660&oldid=2103624250"